Global Lyophilization Services For Biopharmaceuticals Market Major Players 2024, Forecast To 2033
8 Mar, 2024
The lyophilization services for biopharmaceuticals market has experienced rapid growth, increasing from $1.66 billion in 2023 to $1.83 billion in 2024, with a compound annual growth rate (CAGR) of 10.5%. This growth is attributed to expanding biopharmaceuticals and clinical trials. Forecasts suggest further rapid growth, reaching $2.74 billion in 2028, with a CAGR of 10.6%. Factors such as mRNA therapeutics contribute to this expansion. Major trends include automation integration and sustainability focus.
Global Lyophilization Services For Biopharmaceuticals Market Key Driver
The growth trajectory of lyophilization services for biopharmaceuticals is propelled by the increasing demand for biologics, which are therapeutic products derived from living organisms. This demand is reflected in significant spending on biologics in public medication programs, with reports indicating a substantial portion of total spending. Moreover, the approval and availability of numerous biosimilars in the market, as highlighted by the US Food and Drug Administration, underscore the burgeoning demand for biologics, thus driving the need for lyophilization services to maintain product stability and integrity.
Get A Free Sample Of The Global Lyophilization Services For Biopharmaceuticals Market ReportGlobal Lyophilization Services For Biopharmaceuticals Market Segments
The lyophilization services for biopharmaceuticals market covered in this report is segmented –
1) Type:Product And Cycle Development, Clinical Manufacturing, Commercial Manufacturing, Freeze Drying Analytical Services
2) Type Of Primary Packaging System:Vials, Syringes, Cartridges, Ampoules, Other Primary Packaging Systems
3) Application:Pharmaceutical And Biotechnology Companies, Research Institutes, Other Applications
By Geography: The countries covered in the lyophilization services for biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the lyophilization services for biopharmaceuticals market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilization services for biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Lyophilization Services For Biopharmaceuticals Industry Players
Strides Pharma Science Limited; Baxter International Inc.; Catalent Pharma Solutions Inc; W. L. Gore & Associates Inc; Emergent BioSolutions Inc.; Vetter Pharma International GmbH; Curia Global Inc.; Corden Pharma GmbH; CinnaGen Co.; Lyophilization Services of New England Inc.; Jubilant HollisterStier LLC; Dalton Pharma Services; IDT Biologika GmbH; Ardena Group; Axcellerate Pharma LLC; Symbiosis Pharmaceutical Services; Lyka Labs Limited; Biofortuna Limited; Rentschler Fill Solutions GmbH; Lyophilization Technology Inc.; Pyramid Laboratories Inc; ATTWILL Medical Solutions; AB BioTechnologies Inc.; Biopharma Process Systems; Labyrinth Biopharma LLC; Gilyos GmbH; ProJect Pharmaceutics GmbH; BioZed Engineering Pvt. Ltd.; Berkshire Sterile Manufacturing; Millrock Technology Inc.
Get The Full Global Lyophilization Services For Biopharmaceuticals Market Report
Lyophilization Services For Biopharmaceuticals Market Overview
Lyophilization services for biopharmaceuticals refer to freeze-drying biopharmaceutical products to enhance their stability, extend their shelf life, and facilitate storage and transportation. This method preserves and stabilizes biopharmaceuticals by removing water from the product in a frozen state.